Breast Cancer Screening Among Medical Staff in Tehran, Iran: Improvement of Early Detection
Breast cancer is the most prevalent Iranian female malignancy. Breast screening reduces the number of malignant breast diseases. We aimed to assess the results of the pilot breast cancer screening on early detection in female medical staff in Milad Hospital, Tehran, Iran. A cross-sectional study. Female medical staff from Milad Hospital, Tehran, Iran, were examined by a specialist in 2016. A checklist, including demographic data, was completed by the participants. If necessary, they referred to as sonography or mammography. Data were analyzed using SPSS software. Of 746 people enrolled, 137 had no pathological point, 609 had suspicious or positive findings that were referred for further investigation, 449 had normal findings, and 7 had suspicious mass and were biopsied, 6 were benign. One case had primary invasive cancer. Since screening for breast cancer helps to early detection of this disease, the implementation of cancer screening programs should be on the priority of health authorities.
2. Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med 2008;7:6.
3. Thomas E, Escandon S, Lamyian M, Ahmadi F, Setoode SM. Exploring Iranian women's perceptions regarding control and prevention of breast cancer. Qual Rep 2011;16: 1214-29.
4. Humphrey LL, Helfand M, Chan B KS, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
5. Rafiemanesh H, Salehiniya H, Lotfi Z. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends. Asian Pac J Cancer Prev 2016;17: 1393-7.
6. Babu GR, Samari G, Cohen SP, Mahapatra T, Wahbe RM, Mermash S, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev 2011;12:1647-55.
7. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008;27:32.
8. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, et al. NCCN clinical practice guideline in oncology. Breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009;7:1060-96
9. Roohparvarzade N, Ghaderi M, Parsa A, Allahyari A. Prevalence of risk factors for breast cancer in women (20 to 69 Years old) in Isfahan 2012-2013. Iranian Journal of Breast Diseases 2014;7:52-61.
10. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F,
Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26:8-30.
11. Memon ZA, Kanwal N, Sami M, Azam Larik P, Zain Farooq M. Risk of Breast Cancer among Young Women and Importance of Early Screening. Asian Pac J Cancer Prev 2015;16:7485-9.
12. Fathi Najafi T, Jabarzadeh Ganjeh S, Mojahedi Rezaian S, Mazloom SR. Assessment of Certain Breast Cancer Risk Factors During Reproductive Age in Women in Mashhad(2002-2003). Razi Jouranal of Medical Science 2004;11:577-85.
13. Pandey S, Chandravati. Breast Screening in North India: A Cost-Effective Cancer Prevention Strategy. Asian Pac J Cancer Prev 2013;14:853-7.
14. Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women’s Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002;11:1375-81.
15. Kayhan A, Gurdal SO, Ozaydin N, Cabioglu N, Ozturk E, Ozcinar B, et al. Successful First Round Results of a Turkish Breast Cancer Screening Program with Mammography in Bahcesehir, Istanbul. Asian Pac J Cancer Prev 2014;15:1693-7.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.